| Literature DB >> 30837942 |
Lucinda J Black1, Gabrielle S Bowe1, Gavin Pereira1,2, Robyn M Lucas3,4, Keith Dear5, Ingrid van der Mei6, Jill L Sherriff1.
Abstract
The evidence associating red meat consumption and risk of multiple sclerosis is inconclusive. We tested associations between red meat consumption and risk of a first clinical diagnosis of central nervous system demyelination (FCD), often presaging a diagnosis of multiple sclerosis. We used food frequency questionnaire data from the 2003-2006 Ausimmune Study, an incident, matched, case-control study examining environmental risk factors for FCD. We calculated non-processed and processed red meat density (g/1,000 kcal/day). Conditional logistic regression models (with participants matched on age, sex, and study region) were used to estimate odds ratios (ORs), 95% confidence intervals (95% CI) and p-values for associations between non-processed (n = 689, 250 cases, 439 controls) and processed (n = 683, 248 cases, 435 controls) red meat density and risk of FCD. Models were adjusted for history of infectious mononucleosis, serum 25-hydroxyvitamin D concentrations, smoking, race, education, body mass index and dietary misreporting. A one standard deviation increase in non-processed red meat density (22 g/1,000 kcal/day) was associated with a 19% reduced risk of FCD (AOR = 0.81; 95%CI 0.68, 0.97; p = 0.02). When stratified by sex, higher non-processed red meat density (per 22 g/1,000 kcal/day) was associated with a 26% reduced risk of FCD in females (n = 519; AOR = 0.74; 95%CI 0.60, 0.92; p = 0.01). There was no statistically significant association between non-processed red meat density and risk of FCD in males (n = 170). We found no statistically significant association between processed red meat density and risk of FCD. Further investigation is warranted to understand the important components of a diet that includes non-processed red meat for lower FCD risk.Entities:
Keywords: Ausimmune Study; diet; multiple sclerosis; processed meat; red meat
Year: 2019 PMID: 30837942 PMCID: PMC6389668 DOI: 10.3389/fneur.2019.00125
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Characteristics of participants in the Ausimmune Study included in the analysis for non-processed red meat (n = 689; 250 cases, 439 controls) and processed red meat (n = 683; 248 cases, 435 controls).
| Male | 25.2 (63) | 24.4 (107) | 25.4 (63) | 24.1 (105) |
| Female | 74.8 (187) | 75.6 (332) | 74.6 (185) | 75.9 (330) |
| Age, year, mean (SD) | 38.7 (9.7) | 40.0 (9.6) | 38.8 (9.7) | 40.0 (9.6) |
| Brisbane (27°S) | 34.0 (85) | 37.1 (163) | 33.9 (84) | 37.2 (162) |
| Newcastle (33°S) | 12.4 (31) | 14.6 (64) | 11.7 (29) | 14.0 (61) |
| Geelong (37°S) | 23.6 (59) | 24.4 (107) | 24.2 (60) | 24.6 (107) |
| Tasmania (43°S) | 30.0 (75) | 23.9 (105) | 30.2 (75) | 24.1 (105) |
| Race, % (n) | 94.1 (241) | 94.1 (413) | 96.4 (239) | 94.0 (409) |
| Caucasian | 3.6 (9) | 5.9 (26) | 3.6 (9) | 6.0 (26) |
| No | 65.2 (163) | 79.3 (348) | 64.9 (161) | 79.3 (345) |
| Yes | 28.0 (70) | 16.2 (71) | 28.2 ( | 16.1 (70) |
| Don't know | 6.8 (17) | 4.6 (20) | 6.9 (17) | 4.6 (20) |
| Serum 25(OH)D concentrations (nmol/L), mean (SD) | 75.8 (29.7) | 81.9 (30.3) | 75.8 (29.8) | 81.5 (30.6) |
| Total years of smoking, median (IQR) | 5.7 (18.7) | 2.0 (14.8) | 5.4 (18.9) | 1.7 (14.7) |
| Year 10 or less | 24.8 (62) | 33.3 (146) | 25.0 (62) | 33.3 (145) |
| Year 12 and tertiary and further education | 50.0 (125) | 41.7 (183) | 49.2 (122) | 41.2 (179) |
| University | 25.2 (63) | 25.1 (110) | 25.8 (64) | 25.5 (111) |
| Non-processed red meat intake (g/day), median (IQR) | 46.5 (62.1) | 58.7 (57.8) | N/A | N/A |
| Non-processed red meat density (g/1,000 kcal/day), median (IQR) | 28.9 (28.2) | 35.4 (27.4) | N/A | N/A |
| Processed red meat intake (g/day), median (IQR) | N/A | N/A | 18.9 (22.6) | 18.3 (22.1) |
| Processed red meat density (g/1,000 kcal/day), median (IQR) | N/A | N/A | 11.1 (11.2) | 11.0 (10.5) |
| Under-reporter | 42.8 (107) | 40.6 (178) | 42.7 (106) | 40.7 (177) |
| Plausible reporter | 57.2 (143) | 59.5 (261) | 57.3 (142) | 59.3 (258) |
SD, standard deviation; 25(OH)D, 25-hydroxyvitamin D; IQR, interquartile range.
Case and control participants were matched on sex, age (within 2 years) and study region.
Red meat intake (g/day) and density (g/1,000 kcal/day) for male and female participants in the Ausimmune Study included in the current study.
| Intake (g/day), median (IQR) | 63 | 87.4 (108.7) | 107 | 79.4 (83.3) | 187 | 39.1 (49.7) | 332 | 54.2 (53.1) |
| Density (g/1,000 kcal/day), median (IQR) | 63 | 38.6 (31.5) | 107 | 36.5 (26.7) | 187 | 26.9 (24.4) | 332 | 35.05 (27.8) |
| Intake (g/day), median (IQR) | 63 | 29.4 (33.7) | 105 | 27.3 (34.3) | 185 | 15.9 (20.0) | 330 | 16.9 (19.6) |
| Density (g/1,000 kcal/day), median (IQR) | 63 | 12.6 (11.4) | 105 | 12.0 (10.3) | 185 | 10.3 (10.6) | 330 | 10.4 (10.6) |
Results from conditional logistic regressions models showing associations between red meat density (non-processed and processed) and risk of FCD in participants of the Ausimmune Study included in the current study, in the total study sample and stratified by sex.
| Total | 689 (250, 439) | 0.81 (0.68, 0.95) | 0.01 | 0.81 (0.68, 0.97) | 0.02 |
| Males | 170 (63, 107) | 1.06 (0.78, 1.45) | 0.71 | 1.08 (0.73, 1.59) | 0.69 |
| Females | 519 (187, 332) | 0.73 (0.59, 0.89) | 0.002 | 0.74 (0.60, 0.92) | 0.01 |
| Total | 683 (248, 435) | 1.00 (0.85, 1.17) | 0.98 | 1.04 (0.88, 1.22) | 0.67 |
| Males | 168 (63, 105) | 0.92 (0.68, 1.24) | 0.59 | 0.92 (0.66, 1.29) | 0.62 |
| Females | 515 (185, 330) | 1.07 (0.87, 1.30) | 0.53 | 1.10 (0.90, 1.35) | 0.36 |
FCD, first clinical diagnosis of central nervous system demyelination; SD, standard deviation.
Adjusted for history of infectious mononucleosis, serum 25-hydroxyvitamin D concentrations, total years of smoking, body mass index, race, education, and dietary misreporting.
Results from conditional logistic regressions models showing associations between red meat density (non-processed and processed) and (a) risk of FCD including only participants with plausible energy intakes (>500 to < 5,000 kcal/day), (b) risk of FCD in case participants who completed the study interview within 90 days from the date of MRI scan, (c) risk of FDE.
| Total | 676 (430, 246) | 0.81 (0.69, 0.96) | 0.02 | 0.82 (0.69, 0.98) | 0.03 |
| Males | 161 (101, 60) | 1.10 (0.80, 1.50) | 0.57 | 1.14 (0.77, 1.70) | 0.51 |
| Females | 515 (329, 186) | 0.73 (0.59, 0.89) | 0.002 | 0.74 (0.60, 0.92) | 0.01 |
| Total | 316 (115, 201) | 0.86 (0.68, 1.08) | 0.20 | 0.87 (0.67, 1.11) | 0.26 |
| Males | 93 (34, 59) | 1.28 (0.82, 2.01) | 0.28 | 1.69 (0.90, 3.16) | 0.10 |
| Females | 223 (81, 142) | 0.71 (0.53, 0.96) | 0.03 | 0.71 (0.52, 0.97) | 0.03 |
| Total | 519 (191, 328) | 0.82 (0.68, 0.99) | 0.04 | 0.80 (0.65, 0.98) | 0.03 |
| Males | 129 (48, 81) | 1.07 (0.75, 1.51) | 0.72 | 1.07 (0.69, 1.66) | 0.76 |
| Females | 390 (143, 247) | 0.73 (0.58, 0.92) | 0.01 | 0.71 (0.55, 0.92) | 0.01 |
| Total | 670 (426, 244) | 1.00 (0.85, 1.18) | 0.98 | 1.04 (0.88, 1.23) | 0.64 |
| Males | 159 (99, 60) | 0.93 (0.68, 1.27) | 0.64 | 0.92 (0.64, 1.32) | 0.65 |
| Females | 511 (327, 184) | 1.03 (0.86, 1.24) | 0.75 | 1.08 (0.89, 1.31) | 0.45 |
| Total | 313 (114, 199) | 1.00 (0.80, 1.25) | 0.99 | 1.05 (0.82, 1.33) | 0.70 |
| Males | 92 (34, 58) | 1.00 (0.70, 1.43) | 0.996 | 1.02 (0.64, 1.62) | 0.93 |
| Females | 221 (80, 141) | 1.00 (0.75, 1.32) | 0.99 | 1.03 (0.76, 1.40) | 0.83 |
| Total | 518 (190, 328) | 0.99 (0.83, 1.18) | 0.89 | 1.02 (0.85, 1.23) | 0.81 |
| Males | 128 (48, 80) | 0.90 (0.66, 1.24) | 0.53 | 0.94 (0.65, 1.35) | 0.75 |
| Females | 390 (142, 248) | 1.03 (0.83, 1.27) | 0.80 | 1.06 (0.85, 1.33) | 0.58 |
FCD, first clinical diagnosis of central nervous system demyelination; MRI, magnetic resonance imaging; FDE, incident classic first demyelinating event.
Adjusted for history of infectious mononucleosis, serum 25-hydroxyvitamin D concentrations, total years of smoking, body mass index, race, education, and dietary misreporting.